The Long Run with Luke Timmerman
"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
Episodes
Ep150: Jeff Jonker on the Small Molecule Drug Discovery Renaissance
Ep149: Nancy Stagliano on Precision Neuroscience
Ep148: Diana Brainard on the Fight Against Infectious Disease
Ep147: Reid Huber on Investing in the Future of Medicine
Ep146: Jeff Huber on Life in Tech and Biotech
Ep145: Lori Lyons-Williams on Targeted Radiopharmaceuticals for Cancer
Ep144: Turning the Tables, Rob Perez Interviews Me
Ep143: Zach Weinberg and Alexis Borisy on Freeing the Biotech Founders
Ep142: Fred Appelbaum on how 'Living Medicine' Came to Be
Ep141: Colin Hill on Digging Deep into Data, Finding New Drug Targets
Ep140: Yung Lie on Supporting Young Scientists with Bold, Brave Ideas
Follow this podcast in Podwise
Sign in to get AI summaries, transcripts and mind maps for any episode, including new ones.
